Sesen Bio Receives Complete Response Letter from FDA for Vicineum™ (oportuzumab monatox-qqrs)


Business Wire 13 August, 2021 - 01:40pm 30 views

Will sesen bio get FDA approval?

Aug 13 (Reuters) - The U.S. Food and Drug Administration has declined to approve Sesen Bio Inc's lead therapy candidate for a type of bladder cancer, the drug developer said on Friday. ReutersU.S. FDA declines to approve Sesen Bio's bladder cancer treatment

Business Stories